Inside the Doctor’s Studio: Retina

Arshad Khanani, MD, MA
Arshad Khanani, MD, MA
Dr. Khanani is a Managing Partner/Director of Clinical Trials, Sierra Eye Associates and a Clinical Associate Professor, University of Nevada School of Medicine. He is a fellowship trained vitreo-retinal specialist and is certified by The American Board of Ophthalmology. He graduated magna cum laude in chemistry from Washington University in St. Louis with a Bachelors and Masters degree. While at Washington University, Dr. Khanani was honored with The Howard Hughes Medical Institute Research Award.

Dr. Khanani then returned home to Texas and obtained his medical degree at Texas Tech School of Medicine where he received several prestigious research awards. After finishing his internship at Baylor College of Medicine, Dr. Khanani completed his residency in Ophthalmology at Texas Tech School of Medicine. During his residency, he was unanimously elected as Chief Resident.

Dr. Khanani attended The University of Texas – Southwestern Medical Center in Dallas for a two-year fellowship in the medical and surgical treatment of vitreo-retinal diseases.

Due to his strong interest in clinical research, Dr. Khanani has served as a principal investigator for several clinical trials. His articles have been published in numerous ophthalmology journals. Dr. Khanani has also presented his work at major ophthalmology meetings worldwide and has been invited multiple times as a guest speaker nationally and internationally.

Peter Kaiser, MD
Peter Kaiser, MD
Peter K. Kaiser, MD, is a Staff member of the vitreoretinal faculty of the Cole Eye Institute in the Department of Ophthalmology at Cleveland Clinic's main campus. He was appointed in 1997. Dr. Kaiser is the Founding Director of the Digital Optical Coherence Tomography (OCT) Reading Center at the Cole Eye Institute.

Dr. Kaiser received his medical degree magna cum laude from Harvard Medical School in Boston, Mass. He completed an internship in internal medicine at Massachusetts General Hospital, an ophthalmology residency at the Massachusetts Eye and Ear Infirmary in Boston and a retinal fellowship at Bascom Palmer Eye Institute in Miami, Florida.

Actively involved in retinal clinical research, Dr. Kaiser is study chairman of 4 major, multi-center, international clinical trials and is a principal investigator in multiple other trials. Complementing his research endeavors, Dr. Kaiser serves on numerous scientific advisory boards and addresses his research interests as an invited speaker at national and international conferences.

Dr. Kaiser is a major contributor to medical literature having authored several ophthalmology texts, and more than 200 book chapters, original reports, electronic publications and abstracts. He is an associate editor of the American Journal of Ophthalmology, and serves on the editorial boards of Retina, Retina Today, Retinal Physician and Ocular Surgery News.

Dr. Kaiser has been recognized by the American Academy of Ophthalmology and American Society of Retina Specialists with Achievement and Senior Achievement Awards, and is listed in the "Best Doctors in America" list. He is the team ophthalmologist for the Cleveland Browns (National Football League), Cleveland Cavaliers (National Basketball Association) and the Cleveland Indians (Major League Baseball).

Charles C. Wykoff, M.D., PhD
Charles C. Wykoff, M.D., PhD
Overview
Dr. Charles C. Wykoff is a board-certified Medical and Surgical Retina Specialist and ophthalmologist with Retina Consultants of Houston. Leading a top international research facility for vitreoretinal diseases, Dr. Wykoff serves as Director of Research at RCH and the Greater Houston Retina Research Foundation (GHRRF). In addition, he serves as the elected Deputy Chair of Ophthalmology for the Blanton Eye Institute, Houston Methodist Hospital. Dr. Wykoff was awarded the American Academy of Ophthalmology Achievement Award in 2015, the American Society of Retina Specialists Honor Award in 2016 and Senior Honor Award in 2018, and was appointed to the OSN Retina 150 in 2016 as an Innovator in Medical and Surgical Retina.